Effectiveness of an Immune-guided Cytomegalovirus Infection Preventive Strategy Compared to a Universal Prophylactic Strategy in Renal Transplant Patients

PHASE3Not yet recruitingINTERVENTIONAL

Enrollment

144

Participants

Timeline

Start Date

August 31, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

June 1, 2027

Conditions

Kidney Transplant Infection

Interventions

DRUG

ROVALCYTE

"Immuno-guided strategy arm"

All Listed Sponsors

lead

University Hospital, Rouen

OTHER